USA Conjugate Vaccines Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.This protein has a key role in enhancing the immunogenic property of the polysaccharide.

    These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis. The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Conjugate Vaccines market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Conjugate Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Conjugate Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Mitsubishi Tanabe Pharma Corp

    • Sanofi

    • Aurobindo Pharma Ltd

    • Merck & Co Inc

    • Serum Institute of India Pvt Ltd

    • GlaxoSmithKline Plc

    • Integrated Biotherapeutics Inc

    • Pfenex Inc

    • Pfizer Inc

    • Sun Pharmaceutical Industries Ltd

    By Type:

    • Multivalent Conjugate Vaccines

    • Monovalent Conjugate Vaccines

    By End-User:

    • Baby

    • Adult

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Conjugate Vaccines Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Conjugate Vaccines Market Size and Growth Rate of Multivalent Conjugate Vaccines from 2016 to 2027

      • 1.3.2 USA Conjugate Vaccines Market Size and Growth Rate of Monovalent Conjugate Vaccines from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Conjugate Vaccines Market Size and Growth Rate of Baby from 2016 to 2027

      • 1.4.2 USA Conjugate Vaccines Market Size and Growth Rate of Adult from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Conjugate Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Conjugate Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Multivalent Conjugate Vaccines

      • 3.4.2 Market Size and Growth Rate of Monovalent Conjugate Vaccines

    4 Segmentation of Conjugate Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Conjugate Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Conjugate Vaccines in Baby

      • 4.4.2 Market Size and Growth Rate of Conjugate Vaccines in Adult

    5 Market Analysis by Regions

    • 5.1 USA Conjugate Vaccines Production Analysis by Regions

    • 5.2 USA Conjugate Vaccines Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Conjugate Vaccines Landscape Analysis

    • 6.1 West USA Conjugate Vaccines Landscape Analysis by Major Types

    • 6.2 West USA Conjugate Vaccines Landscape Analysis by Major End-Users

    7 South USA Conjugate Vaccines Landscape Analysis

    • 7.1 South USA Conjugate Vaccines Landscape Analysis by Major Types

    • 7.2 South USA Conjugate Vaccines Landscape Analysis by Major End-Users

    8 Middle West USA Conjugate Vaccines Landscape Analysis

    • 8.1 Middle West USA Conjugate Vaccines Landscape Analysis by Major Types

    • 8.2 Middle West USA Conjugate Vaccines Landscape Analysis by Major End-Users

    9 Northeast USA Conjugate Vaccines Landscape Analysis

    • 9.1 Northeast USA Conjugate Vaccines Landscape Analysis by Major Types

    • 9.2 Northeast USA Conjugate Vaccines Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Mitsubishi Tanabe Pharma Corp

        • 10.1.1 Mitsubishi Tanabe Pharma Corp Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Sanofi

        • 10.2.1 Sanofi Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Aurobindo Pharma Ltd

        • 10.3.1 Aurobindo Pharma Ltd Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Merck & Co Inc

        • 10.4.1 Merck & Co Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Serum Institute of India Pvt Ltd

        • 10.5.1 Serum Institute of India Pvt Ltd Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 GlaxoSmithKline Plc

        • 10.6.1 GlaxoSmithKline Plc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Integrated Biotherapeutics Inc

        • 10.7.1 Integrated Biotherapeutics Inc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Pfenex Inc

        • 10.8.1 Pfenex Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Pfizer Inc

        • 10.9.1 Pfizer Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Sun Pharmaceutical Industries Ltd

        • 10.10.1 Sun Pharmaceutical Industries Ltd Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Conjugate Vaccines Market Size and Growth Rate of Multivalent Conjugate Vaccines from 2016 to 2027

    • Figure USA Conjugate Vaccines Market Size and Growth Rate of Monovalent Conjugate Vaccines from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Conjugate Vaccines Market Size and Growth Rate of Baby from 2016 to 2027

    • Figure USA Conjugate Vaccines Market Size and Growth Rate of Adult from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Conjugate Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Conjugate Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Conjugate Vaccines

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Conjugate Vaccines by Different Types from 2016 to 2027

    • Table Consumption Share of Conjugate Vaccines by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Multivalent Conjugate Vaccines

    • Figure Market Size and Growth Rate of Monovalent Conjugate Vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Conjugate Vaccines by Different End-Users from 2016 to 2027

    • Table Consumption Share of Conjugate Vaccines by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Baby

    • Figure Market Size and Growth Rate of Adult

    • Table USA Conjugate Vaccines Production by Regions

    • Table USA Conjugate Vaccines Production Share by Regions

    • Figure USA Conjugate Vaccines Production Share by Regions in 2016

    • Figure USA Conjugate Vaccines Production Share by Regions in 2021

    • Figure USA Conjugate Vaccines Production Share by Regions in 2027

    • Table USA Conjugate Vaccines Consumption by Regions

    • Table USA Conjugate Vaccines Consumption Share by Regions

    • Figure USA Conjugate Vaccines Consumption Share by Regions in 2016

    • Figure USA Conjugate Vaccines Consumption Share by Regions in 2021

    • Figure USA Conjugate Vaccines Consumption Share by Regions in 2027

    • Table West USA Conjugate Vaccines Consumption by Types from 2016 to 2027

    • Table West USA Conjugate Vaccines Consumption Share by Types from 2016 to 2027

    • Figure West USA Conjugate Vaccines Consumption Share by Types in 2016

    • Figure West USA Conjugate Vaccines Consumption Share by Types in 2021

    • Figure West USA Conjugate Vaccines Consumption Share by Types in 2027

    • Table West USA Conjugate Vaccines Consumption by End-Users from 2016 to 2027

    • Table West USA Conjugate Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Conjugate Vaccines Consumption Share by End-Users in 2016

    • Figure West USA Conjugate Vaccines Consumption Share by End-Users in 2021

    • Figure West USA Conjugate Vaccines Consumption Share by End-Users in 2027

    • Table South USA Conjugate Vaccines Consumption by Types from 2016 to 2027

    • Table South USA Conjugate Vaccines Consumption Share by Types from 2016 to 2027

    • Figure South USA Conjugate Vaccines Consumption Share by Types in 2016

    • Figure South USA Conjugate Vaccines Consumption Share by Types in 2021

    • Figure South USA Conjugate Vaccines Consumption Share by Types in 2027

    • Table South USA Conjugate Vaccines Consumption by End-Users from 2016 to 2027

    • Table South USA Conjugate Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Conjugate Vaccines Consumption Share by End-Users in 2016

    • Figure South USA Conjugate Vaccines Consumption Share by End-Users in 2021

    • Figure South USA Conjugate Vaccines Consumption Share by End-Users in 2027

    • Table Middle West USA Conjugate Vaccines Consumption by Types from 2016 to 2027

    • Table Middle West USA Conjugate Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Conjugate Vaccines Consumption Share by Types in 2016

    • Figure Middle West USA Conjugate Vaccines Consumption Share by Types in 2021

    • Figure Middle West USA Conjugate Vaccines Consumption Share by Types in 2027

    • Table Middle West USA Conjugate Vaccines Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Conjugate Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Conjugate Vaccines Consumption Share by End-Users in 2016

    • Figure Middle West USA Conjugate Vaccines Consumption Share by End-Users in 2021

    • Figure Middle West USA Conjugate Vaccines Consumption Share by End-Users in 2027

    • Table Northeast USA Conjugate Vaccines Consumption by Types from 2016 to 2027

    • Table Northeast USA Conjugate Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Conjugate Vaccines Consumption Share by Types in 2016

    • Figure Northeast USA Conjugate Vaccines Consumption Share by Types in 2021

    • Figure Northeast USA Conjugate Vaccines Consumption Share by Types in 2027

    • Table Northeast USA Conjugate Vaccines Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Conjugate Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Conjugate Vaccines Consumption Share by End-Users in 2016

    • Figure Northeast USA Conjugate Vaccines Consumption Share by End-Users in 2021

    • Figure Northeast USA Conjugate Vaccines Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma Corp

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma Corp

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma Corp

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma Corp

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Aurobindo Pharma Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma Ltd

    • Figure Sales and Growth Rate Analysis of Aurobindo Pharma Ltd

    • Figure Revenue and Market Share Analysis of Aurobindo Pharma Ltd

    • Table Product and Service Introduction of Aurobindo Pharma Ltd

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of Serum Institute of India Pvt Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India Pvt Ltd

    • Figure Sales and Growth Rate Analysis of Serum Institute of India Pvt Ltd

    • Figure Revenue and Market Share Analysis of Serum Institute of India Pvt Ltd

    • Table Product and Service Introduction of Serum Institute of India Pvt Ltd

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Integrated Biotherapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Integrated Biotherapeutics Inc

    • Figure Sales and Growth Rate Analysis of Integrated Biotherapeutics Inc

    • Figure Revenue and Market Share Analysis of Integrated Biotherapeutics Inc

    • Table Product and Service Introduction of Integrated Biotherapeutics Inc

    • Table Company Profile and Development Status of Pfenex Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfenex Inc

    • Figure Sales and Growth Rate Analysis of Pfenex Inc

    • Figure Revenue and Market Share Analysis of Pfenex Inc

    • Table Product and Service Introduction of Pfenex Inc

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Sun Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Sun Pharmaceutical Industries Ltd


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.